Model Number 9-PFO-025 |
Device Problem
Biocompatibility (2886)
|
Patient Problems
Arrhythmia (1721); Atrial Flutter (1730); Ventricular Tachycardia (2132)
|
Event Date 06/24/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
The results/method and conclusion codes along with investigation results will be provided in a subsequent submission.
|
|
Event Description
|
On (b)(6) 2020, a 25mm amplatzer pfo occluder was successfully implanted.On (b)(6) 2020 (9 days post-implant), the patient presented to the emergency department with palpitations.Echocardiogram was performed and showed supra ventricular tachycardia (svt).The patient was reported to have 3:1 atrial flutter and rate control was attempted with medical intervention (verapamil).The device remains implanted and the patient is reportedly stable.
|
|
Manufacturer Narrative
|
An event of a patient implanted with an amplatzer pfo occluder having supra ventricular tachycardia nine days post-implantation was reported.A more comprehensive assessment could not be performed as the device remains implanted was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.
|
|
Search Alerts/Recalls
|